Boston Scientific Corporation filed an 8-K with the Securities and Exchange Commission on November 17, 2026, disclosing Board approval of its 2027 Annual Bonus Plan and two 2027 Performance Share Programs covering the January 1, 2027 through December 31, 2029 performance periods.
Key Highlights
- 2027 Annual Bonus Plan approved: The Board approved the plan on November 17, 2026, upon the recommendation of the Executive Compensation and Human Resources Committee, effective for the performance year January 1, 2027 through December 31, 2027.
- Distribution percentage range: The Compensation Committee will determine the applicable distribution percentage between 0% and 150%, based on global sales and adjusted earnings per share performance.
- Dynamic bonus pool: The plan includes a dynamic bonus pool equal to 10% or less of total target annual bonuses for all plan participants.
- Individual payout range: Each participant's final bonus award may range from 0% to 225% of individual target bonus, based on the distribution percentage and an individual performance modifier of 0% to 150%.
- Two performance share programs adopted: The Board approved the 2027 Relative Total Shareholder Return Performance Share Program (2027 rTSR PSP) and the 2027 Organic Net Sales Growth Performance Share Program (2027 Organic Net Sales PSP), each covering January 1, 2027 through December 31, 2029.
- Performance share award range: Under both programs, the number of performance shares awarded will range from 0% to 200% of each participant's target number of awards.
- Clawback provisions apply: Awards under all three plans are subject to the company's discretionary recoupment policy and its Dodd-Frank Clawback Policy.
Boston Scientific's 2027 Executive Compensation Framework: Bonus and Equity Plans
According to the filing, the 2027 Annual Bonus Plan is "substantially similar to the 2026 annual bonus plan" and provides an annual cash incentive opportunity for eligible personnel, including named executive officers meeting eligibility criteria. The aggregate bonus pool is calculated as the total target annual bonuses for all participants multiplied by the applicable distribution percentage, with a separate dynamic bonus pool capped at 10% or less of total target bonuses. The Compensation Committee will set the distribution percentage, between 0% and 150%, after the close of the performance year, measuring the company's results against goals for global sales and adjusted earnings per share. The filing notes the Board retains discretion to terminate, suspend, or modify the plan and to reduce the distribution percentage based on quality objectives and quality systems performance.
The two performance share programs, the filing states, "represent an important component of the overall mix of the Company's long-term incentive program." The 2027 rTSR PSP measures Boston Scientific's total shareholder return relative to other companies in the S&P 500 Healthcare Index over the three-year period ending December 31, 2029. The 2027 Organic Net Sales PSP measures organic net sales growth, defined in the filing as net sales excluding the impact of foreign currency fluctuation and the impact of certain acquisitions and divestitures for which there are less than a full period of comparable net sales, against the company's financial plan. Both programs provide for awards in a range of 0% to 200% of each participant's target, issued as restricted stock units under the company's Amended and Restated 2011 Long-Term Incentive Plan.
The filing also specifies that if a participant's employment terminates due to retirement, as defined in the 2027 rTSR PSP, prior to January 1, 2028, performance share awards under that program will be forfeited in their entirety. Awards under all three plans are subject to both the company's discretionary recoupment policy and its Dodd-Frank Clawback Policy, as disclosed. Boston Scientific's common stock is listed on the NYSE under the symbol NYSE:BSX.
What Was Disclosed
Boston Scientific disclosed Board approval of three executive compensation arrangements for 2027: an annual cash bonus plan covering January 1 through December 31, 2027, and two performance share programs spanning January 1, 2027 through December 31, 2029, all subject to clawback provisions.




Please wait processing your request...